SeaStar’s Patent Splash: Medical Device Technology Granted Canadian Protection
SeaStar Medical Holding Corporation has reportedly expanded its intellectual property portfolio with the grant of Canadian Patent No. 2,814,586. The patent protects the company’s Selective Cytopheretic Device (“SCD”) technology, which reportedly plays a role in mitigating the severe effects of hyper-inflammation on vital organs.
The SCD technology developed by SeaStar Medical presents a solution to the challenges posed by dysregulated hyper-inflammatory responses. Such responses can lead to extensive organ damage and are potentially fatal. The SCD’s mechanism focuses on targeting overactive inflammatory cells, aiming to suppress the excessive inflammatory reaction associated with various medical conditions and possibly reversing the damage caused to organs.
The new Canadian patent, titled “Cytopheretic Cartridge and Use Thereof,” includes the SCD cartridges designed to treat and process activated leukocytes and platelets. The addition of this patent builds upon SeaStar Medical’s existing patents in the United States.
Author: PJ Conlon, 2023/2024 Articling Student-At-Law
Expertise
Insights
-
Intellectual Property
SeaStar’s Patent Splash: Medical Device Technology Granted Canadian Protection
SeaStar Medical Holding Corporation has reportedly expanded its intellectual property portfolio with the grant of Canadian Patent No. 2,814,586. The patent protects the company’s Selective… -
Intellectual Property
Enveric Biosciences Sells Cannabinoid-Related IP to Focus on Emerging Psychedelic-Inspired Drugs
Enveric Biosciences (“Enveric”) has reportedly now sold one of its portfolios comprised of patents and patent applications for cancer treatment that combines cannabidiol (“CBD”) with additional… -
Intellectual Property
US Patent and Trademark Office Comments on AI-Assisted Inventions
While AI’s rapid development and ever-increasing proliferation have facilitated substantial efficiency gains across a myriad of industries, unanswered legal questions regarding the consequences of its… -
Intellectual Property
OpenAI’s “GPT” Trademark Application Rejected by USPTO
The US Patent and Trademark Office (“USPTO”) has rejected OpenAI’s application to trademark “GPT”, which stands for Generative Pre-trained Transformer, saying the term was “merely… -
Intellectual Property
Art Teacher and School Board Face a Brush with the Law
Upon discovering approximately 3,000 pieces of their children’s artwork for sale online without consent, a group of parents in Quebec have threatened legal action against a junior high school art… -
Intellectual Property
Four New Patents Join EA’s Accessibility Pledge
Electronic Arts (“EA”) continues to break down barriers, adding four more patents to its accessibility Patent Pledge.In 2021, EA introduced a Patent Pledge with the aim of fostering a more accessible…